Electropharmacology of nifekalant, a new class III antiarrhythmic drug

被引：22

作者：

Nakaya, H ^{[1
]}

Uemura, H ^{[1
]}

机构：

[1] Chiba Univ, Sch Med, Dept Pharmacol, Chuo Ku, Chiba 2608670, Japan

来源：

CARDIOVASCULAR DRUG REVIEWS | 1998年 / 16卷 / 02期

关键词：

action potential; arrhythmias; heart; ionic currents; K+ channels; nifekalant;

D O I：

10.1111/j.1527-3466.1998.tb00350.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：133 / 144

页数：12

共 42 条

[1]

[Anonymous], 1989, NEW ENGL J MED, V321, P406

[2] Myocardial potassium channels: Electrophysiological and molecular diversity [J].

Barry, DM ;

Nerbonne, JM .

ANNUAL REVIEW OF PHYSIOLOGY, 1996, 58 :363-394

[3] INSIGHTS INTO THE ELECTROPHYSIOLOGY STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING TRIAL - ITS PROGRAMMED STIMULATION PROTOCOL MAY INTRODUCE BIAS WHEN ASSESSING LONG-TERM ANTIARRHYTHMIC DRUG-THERAPY [J].

BIBLO, LA ;

CARLSON, RD ;

WALDO, AL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (07) :1601-1604

[4]

BLACK SC, 1991, J PHARMACOL EXP THER, V258, P416

[5]

Block M, 1995, CARDIAC ELECTROPHYSI, P1412

[6]

CARMELIET E, 1992, J PHARMACOL EXP THER, V262, P809

[7] I-K independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats [J].

Chen, JG ;

Komori, S ;

Li, BH ;

Tamura, K ;

Hashimoto, K .

BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (05) :937-942

[8]

Cheng JH, 1996, CARDIOVASC RES, V31, P963

[9] ANTIARRHYTHMIC AGENT, MS-551, PROTECTS AGAINST PINACIDIL PLUS HYPOXIA-INDUCED VENTRICULAR-FIBRILLATION IN LANGENDORFF-PERFUSED RABBIT ISOLATED HEART [J].

FRIEDRICHS, GS ;

CHI, LG ;

BLACK, SC ;

MANLEY, PJ ;

LUCCHESI, BR .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (01) :120-126

[10] MS-551 PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CHRONIC CANINE MODEL OF SUDDEN CARDIAC DEATH [J].

FRIEDRICHS, GS ;

CHI, L ;

GRALINSKI, MR ;

BLACK, SC ;

BASLER, GC ;

MU, DX ;

PEWITT, SR ;

JOHNSON, CR ;

LUCCHESI, BR .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (02) :314-323

← 1 2 3 4 5 →